Cost-effectiveness of first- v. second-generation antipsychotic drugs: Results from a randomised controlled trial in schizophrenia responding poorly to previous therapy

Linda M. Davies, Shôn Lewis, Peter B. Jones, Thomas R E Barnes, Fiona Gaughran, Karen Hayhurst, Alison Markwick, Helen Lloyd

Research output: Contribution to journal › Article › peer-review

1 results
- Title(descending)

CUtLASS: Changing attitudes and prescribing practice: cost effectiveness of first versus second generation antipsychotic drugs in people with schizophrenia
Lewis, S. (Participant), Dunn, G. (Participant) & Davies, L. (Participant)
Impact: Health impacts, Economic impacts